Robust IL-2-dependent antitumor immunotherapy requires targeting the high-affinity IL-2R on tumor-specific CD8<sup>+</sup> T cellsKathryn M LaPorte, Thomas R. Malek|Journal for ImmunoTherapy of Cancer|2023Cited by 27
Three Loops of the Common γ Chain Ectodomain Required for the Binding of Interleukin-2 and Interleukin-7Ferenc Olosz, Thomas R. Malek|Journal of Biological Chemistry|2000Cited by 25
CD25 and Protein Phosphatase 2A Cooperate to Enhance IL-2R Signaling in Human Regulatory T CellsYing Ding, Thomas R. Malek|The Journal of Immunology|2019Cited by 18